A commonly prescribed drug easing nerve pain is now associated with dementia and cognitive impairment.

Regular gabapentin use appeared to increase risk of dementia by 29% and mild cognitive impairment (MCI) by 85%, researchers ...

A drug widely used to treat nerve pain and epilepsy has been linked with an increase in cases of dementia and mild cognitive ...

OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to ...

A new study in the journal Pharmacy says that patients with chronic pain who used marijuana for at least one year “exhibited ...

For chronic pain patients, though, the brain interprets even neutral sensations as pain and suffering. In effect, pain ...

After 12 weeks of treatment, 75% of per-protocol patients receiving 0.05% urcosimod showed greater than 80% reduction in ...

Compared with other interventions, GNB was effective for pain relief and functional improvement among patients with knee OA.

Patients with a mysterious eye pain disease may be one step closer to seeing the first approved treatment for their condition ...

Chronic Pain Market Epidemiology Report 2025-2035: Drugs Pipeline, Therapies, and Forecast The report provides a detailed analysis of the current chronic pain marketed drugs and late-stage pipeline ...

Nerves are bundles of nerve fibers that act as communication lines of our system, transmitting signals between the brain and ...